Podcast Summary
In Episode 49 of the Pound of Cure Weight Loss Podcast, Dr. Weiner and Zoe examine the steep costs of obesity medications like Wegovy, the influence of pharmacy benefit managers (PBMs), and the role of big pharmaceutical companies in shaping healthcare. Highlighting recent Senate hearings led by Bernie Sanders with Novo Nordisk’s CEO Lars Fruergaard Jørgensen, this episode sheds light on how the current system prioritizes profit, often at the expense of patients’ access to care. Wegovy Cost: ...
In this episode of The Pound of Cure Podcast, Dr. Matthew Weiner and Zoë Schroeder discuss the practical weight loss lessons behind Novo Nordisk’s Weekend at Bernie’s. The conversation connects medical weight loss, bariatric surgery, GLP-1 medications, nutrition, and long-term metabolic health.
Patients who are comparing treatment options can use this episode to better understand how evidence-based obesity care works in real life, including the role of food quality, medication support, surgery, mindset, and ongoing follow-up.
Talk with our team
Have questions about this episode?
Send our Tucson weight loss team a note about bariatric surgery, GLP-1 medications, nutrition, or your next step with Pound of Cure.
More from this episode
This episode includes a full transcript. The detailed episode guide should be regenerated from that transcript when AI summary generation is available.
Weight loss topics covered in this episode
This conversation is part of the Pound of Cure approach to evidence-based weight loss education, including bariatric surgery, GLP-1 medications, nutrition counseling, metabolic health, and long-term patient support.
For more context, explore our guides to GLP-1 medications, bariatric surgery in Tucson, and the Metabolic Reset Diet.